Advertisement
Screener

Intellicell Biosciences, Inc. Proceeds from Contributed Capital

Intellicell Biosciences, Inc. Proceeds from Contributed Capital

Intellicell Biosciences, Inc. reported Proceeds from Contributed Capital of $700 for the 17-month period ending 2010-12-31, per its 10-K/A filed 2012-04-23.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromContributedCapital · last filed 2012-04-23

  • 2010-12-31: Proceeds from Contributed Capital 17 month $700.00.
Period endProceeds from Contributed Capital 17 month
2010-12-31$700.00
10-K/A · filed 2012-04-23